Public release date: 4-Mar-2013 [ | E-mail | Share ] Contact: Jessica Studeny jessica.studeny@case.edu 216-368-4692 Case Western Reserve University A professor from Case Western Reserve University School of Medicine is one of the lead authors of a study identifying seven new regions of the human genome that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness among older adults. The AMD Gene Consortium, a network of international investigators representing 18 research groups, also confirmed the existence of 12 other regions called loci that had been identified in previous studies. The authors report their findings online in the journal Nature Genetics. Supported by the National Eye Institute (NEI), a part of the National Institutes of Health, the study represents the most comprehensive genome-wide analysis of genetic variations associated with AMD. "This work represents a big step forward toward solving why some people get AMD, while others do not," said Sudha Iyengar, PhD, professor of epidemiology and biostatistics at Case Western Reserve School of Medicine and a member of the consortium's senior executive committee. "This disease is not caused by a single change in the DNA, but represents many events that accumulate over the lifetime of … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that Genzymes Head of Rare Diseases, Rogerio Vivaldi, MD, has been honored as the Genetic Disease Foundations Industry Person of the Year. The award is given to an individual in the life sciences industry who has made outstanding contributions to advancing medical research and bringing new therapies to people living with rare genetic diseases. For more than 20 years, Dr. Vivaldi has worked to identify the unmet needs of those living with rare genetic diseases, such as Gaucher disease, said Elisa Ross, President of the Genetic Disease Foundation (GDF). We are pleased to recognize Dr. Vivaldi for his dedication and commitment to improving patients lives. The award will be presented tonight at the GDF Gala at New Yorks Gotham Hall.The eventwill raise funds for the Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai. I am truly honored by this award. As a physician in Brazil, I saw firsthand the importance of diagnosis and treatment for rare genetic diseases, said Dr. Vivaldi. At Genzyme we continue the mission to develop and deliver transformative therapies to all patients affected by rare genetic diseases. … Continue reading →

Diabetes: stem cells? We take a look at stem cell applications and diabetes. By: Thomas Duke … Continue reading →

Parkinson's Disease: Stem Cell Treatments (Biology 3:30 PM Group 47) Parkinson's Disease: Stem Cell Treatments Group #47 (Katy Fuqua, Tyler Johnson, Shelby Settle, Nuri Kim, Tim Van Zant, Sarah Wingate) By: swingate1000 … Continue reading →

Stem Cell Application, Group 55 11am Stem Cell Application, Group 55 11am By: Olivia Frost … Continue reading →

Group2am bio1103 Alzheimer's stem cell treatment By: Missymeemee … Continue reading →

Stem Cell Application - Group 41 PM Stem Cell Application towards vision impairment By: John Smith … Continue reading →

Post Regenexx Stem Cell Treatment Results for JR's Knee | Rejuv Medical, Minnesota JR Burgess had a sport related knee injury. JR, went to Joel Baumgartner, MD to under go the stem cell injections for regenerative growth in his knee. Rejuv Medical has been following JR's incredible results and recovery from the stem cell procedure that he has had done at Rejuv Medical of Saint Cloud, MN. http://www.rejuvmedical.com By: Rejuv Medical … Continue reading →

Floppy infant , treated by stem cells This patient was completely floppy , and after treatment with stem cell , now can sit and crawl , her mentality improved too much , no more treatment needed By: nadher abed … Continue reading →

Nanoparticle drug delivery in cancer therapy Nanobotmodels Company presents vision of modern drug delivery methods using DNA-origami nanoparticles. In animation you can see cancer therapy using doxorubicin, delivered by nanomedicine methods. Read more in article: http://www.nanobotmodels.com By: Nanobotmodels … Continue reading →